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Background/Introduction 
Overweight (OW) and low fit (LF) children have a clustered risk for later cardiovascular disease. 
We therefore investigated, whether a preschool-based lifestyle intervention was effective in OW 
and LF children. 
 
Methods 
Forty preschool classes were randomly selected and 1:1 randomized into an intervention and a 
control arm after stratification for language region (French vs. German part of Switzerland). The 
intervention included a physical activity (PA) program, lessons on eating habits, media use and 
sleep, and adaptation of the built environment. Primary outcomes were changes in BMI and 
aerobic fitness; secondary outcomes changes in percent body fat, sum of 4 skinfolds (SF), waist 
circumference and motor agility. Potential interactions of intervention with high baseline BMI (OW 
≥90th national percentile) and low fitness (lowest sex- and age-adjusted quartile of aerobic fitness) 
were tested and stratified analyses performed. 
 
Results 
652 preschool children (mean age 5.2 ± 0.6 yrs, 20% OW, 25% LF) participated. In the total 
population, the intervention had beneficial effects on body fat and both fitness measures. 
Compared to their counterparts, OW children experienced more beneficial ef-fects for most and LF 
children for all adiposity measures (p for interactions <0.1), while there were no interactions for 
fitness measures. OW children showed a significant inter-vention effect (adjusted changes (95% 
CI)) in sum of 4 SF (-3.6 mm (-6.5 to -0.8 mm), p=0.011), waist circumference (-2.2 cm (-3.2 to -1.2 
cm), p<0.001) and agility (-1.0 s (-1.9 to -0.1 s), p=0.023). LF children showed a significant 
intervention effect in BMI (-0.3 kg/m2 (-0.5 to -0.03 kg/m2), p=0.014), percent body fat (-2.1% (3.2 
to -1.0%), p<0.001), sum of 4 SF (-5.0 mm (-7.4 to -2.7 mm), p<0.001) and waist circumference (-
1.62 cm (-2.7 to -0.5 cm), p=0.004) but not in fitness measures.  
 
Conclusion 
This intervention was also effective in high risk preschoolers and represents a promising option for 
OW and LF children.  
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Background/Introduction 
Some genetic markers have shown an association with Type 2 Diabetes Mellitus (T2DM). 
Considering the potential costs of genetic screening, the predicting value of such markers needs to 
be assessed. In this study, we aimed to assess the extra clinical value of several previously 
published genetic risk scores compared to a clinical + biological risk score. 
 
Methods 
Prospective study conducted in 2,113 participants free from diabetes at baseline, from Lausanne, 
Switzerland, followed for 5 years (overall study period 2003-2011). Incident diabetes was defined 
as fasting plasma glucose (FPG) ≥ 7.0 mmol/L and/or presence of oral hypoglycemic or insulin 
treatment. Different genetic risk scores for T2DM were computed using published data. Their 
predicting effect was assessed separately after adjustment for an established risk score including 
clinical and biological variables. 
 
Results 
112 participants (5.3 %) developped T2DM during follow-up. On bivariate analysis, no significant 
differences were found between diabetic and nondiabetic participants for all the genetic scores 
studied. After adjusting for a clinical + biological risk score, no improvements were found regarding 
the area under the ROC curve (AROC), sensitivity, specificity and predictive values 
 
Conclusion 
In this study, adding genetic information to a clinical + biological risk score does not seem to 
improve prediction of T2DM. Further studies or follow-up time may be needed to precisely assess 
the importance of genetic scores in predicting T2DM. 
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Background/Introduction 
Several risk scores for Type 2 Diabetes Mellitus (T2DM) have been developed, but few studies 
have compared them in the same population. The aim of this study was to assess the validity of 
various T2DM risk scores in predicting the incidence of T2DM in Switzerland. 
 
Methods 
We selected seven published risk scores which included clinical and biological variables. We 
tested them in 3,060 non-diabetic participants from Lausanne, Switzerland, followed for 5 years 
(overall study period 2003-2011). Incident diabetes was defined as fasting plasma glucose (FPG) ≥ 
7.0 mmol/L and/or presence of oral hypoglycemic or insulin treatment. The Area under the ROC 
curve (AROC), sensitivity, specificity, negative and positive predictive values were assessed. 
 
Results 
After 5 years follow-up, 169 patients (5.5%) developed T2DM. The AROC of the seven tested 
scores ranged between 76.1 and 89.9%. They also presented a high specificity (85.2 to 99.1%) 
and a high negative predictive value (94.8 to 97.7%). Conversely, their sensitivity was rather low 
(10.1 to 65.7%), which was also the case for their positive predictive values (17.8 to 35.7%). The 
highest AROC was found using clinical + biological score from Kahn et al. (89.9%) followed by the 
clinical FINDRISC score (85.1%), and the online score from the Swiss Diabetes Association 
(84.7%)   
 
Conclusion 
The clinical + biological risk score from Kahn et al. has the highest AROC, but the clinical 
FINDRISC score may be more practical and less expensive for screening. Further research is 
needed to assess the real impact of these scores in preventing T2DM. 
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Background 
Phenylketonuria (PKU) is an autosomal-recessiv metabolic disease (incidence 1:17’000 births). It is 
characterized by a decreased activity of the enzyme phenylalanine-hydroxylase that metabolizes the 
essential amino acid phenylalanine (Phe) to tyrosine (Tyr). Increased levels of Phe during childhood are 
associated with severe neurological impairment. Assessment of Phe-levels is part of the neonatal-
screening program in Switzerland since 1960s. Data on long-term follow-up is scant. In particular, data 
on schooling, apprenticeship and the integration of these patients in the professional life is currently not 
available. We, therefore, retrospectively analyzed patients with PKU that were treated throughout 
childhood and adulthood at the University Hospital of Bern. 
 
Methods 
All patients with PKU that are currently treated at the Division of Endocrinology, Diabetology and 
Clinical Nutrition of the Inselspital were included. Time point of diagnosis (neonatal screening vs later) 
and additional specialized schooling support (logopedia, ergotherapy, specific legasthenia training, 
special school-classes) were recorded. Accomplished apprenticeship and higher school diploma as well 
as inability to complete a professional formation or patients with disability annuity (IV) in adulthood were 
documented. All the available Phe-levels were recorded and a mean Phe-concentration/year/patient 
was calculated. Time period of observation was chosen according to the guidelines of the Swiss 
metabolic group for the follow-up of patients with PKU, i.e. 0-2 year, 2-10 years and >10 years old.  
 
Results 
Twenty-seven patients (13 females, 14 males) were included. The mean (SD) age at the last visit was 
27.4 (7.9), years. The mean (SD) follow-up period was 25.1 (7.6) years. Twenty-three patients were 
diagnosed by neonatal screening, the remaining 4 patients later (the latest time point was after 3.8 
years). The Phe levels during follow-up of these two groups were not significantly different.  15 % (4 
patients) of the patients completed high school or are at the university. All were diagnosed at neonatal 
screening and mean (SD) Phe levels were: 0-2 years: 360 (62)umol/L ; 2-10 years 320 (62)umol; > 10 
years: 379 (78) umol/L. 59 % (16 patients) accomplished a apprenticeship. All were diagnosed at 
neonatal screening and mean (SD) Phe levels were: 0-2 years: 457 (155)umol/L ; 2-10 years 450 
(124)umol; > 10 years: 708 (286) umol/L. Seven patients (26%) receive disability annuity or were not 
able to accomplish apprenticeship. Five of them were diagnosed after the neonatal period. Mean (SD) 
Phe levels were: 2-10 years: 679 (287)umol/L; > 10 years: 747 (310). Significant differences in Phe 
levels between the three groups (high school, apprenticeship and disability annuity) can be documented 
between 2-10 years of age with highest levels in the disability group followed by the apprenticeship and 
the high school group (ANOVA p<0.01). Additional specialized schooling support was necessary in 52% 
of the patients including in 2 patients that were able to graduate at high school. 
 
Conclusion 
1) Patients with PKU that are diagnosed at neonatal screening and are consequently cared for during 
childhood and adulthood are able to live an independent professional life. 
2) The time of diagnosis is essential for the professional careers.  
3) The exposition to elevated Phe levels during childhood (0-10 years) may contribute to the 
professional success of the patients. 
4) Additional specialized schooling support is necessary in a substantial part of the patients. 
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